Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10+ diffuse large B-cell lymphoma and follicular lymphoma.,Cytometry Part B: Clinical Cytometry

当前位置： X-MOL 学术 › Cytom. Part B Clin. Cytom. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10+ diffuse large B-cell lymphoma and follicular lymphoma.
Cytometry Part B: Clinical Cytometry ( IF 2.3 ) Pub Date : 2019-12-09 , DOI: 10.1002/cyto.b.21861
David Azoulay _{1,

2} , Hector I Cohen ₃ , Eugene Dementiev ₃ , Elizabeth Eshel ₄ , Luiza Akria _{1,

2} , Ety Shaoul _{1,

2} , Netanel Horowitz ₅

Affiliation

Differential diagnosis between diffuse large B‐cell lymphoma (DLBCL) and follicular lymphoma (FL) becomes a challenge when adequate biopsy is unavailable. The present study aimed to investigate the applicability of DNA cell cycle analysis by flow cytometry (FC) for differentiating between CD10⁺ DLBCL and FL.

中文翻译：

流式细胞术非整倍性和细胞周期索引作为区分 CD10+ 弥漫性大 B 细胞淋巴瘤和滤泡性淋巴瘤的可能工具。

当无法进行足够的活检时，弥漫性大 B 细胞淋巴瘤 (DLBCL) 和滤泡性淋巴瘤 (FL) 之间的鉴别诊断就成为一个挑战。本研究旨在研究通过流式细胞术 (FC) 进行的 DNA 细胞周期分析在区分 CD10 ⁺ DLBCL 和 FL 方面的适用性。

更新日期：2019-12-09

点击分享查看原文

点击收藏

阅读更多本刊最新论文